Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.5900 (3.68%) ($9.5900 - $9.5900) on Thu. Mar. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.94% (three month average) | RSI | 59 | Latest Price | $9.5900(3.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(50%) IBB(47%) ARKG(46%) ARKK(46%) IWO(41%) | Factors Impacting ATRA price | ATRA will decline at least -2.47% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-17%) USO(-10%) UUP(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.47% (StdDev 4.94%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $9.6 | 5 Day Moving Average | $9.57(0.21%) | 10 Day Moving Average | $9.28(3.34%) | 20 Day Moving Average | $9.6(-0.1%) | To recent high | -44.4% | To recent low | 13.6% | Market Cap | $713m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |